Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-17-012934)

Filing Details

Accession Number:: 0000899243-17-012934
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-05-11 20:33:08
Reporting Period:: 2017-05-10

Filing Date:: 2017-05-11
Accepted Time:: 2017-05-11 20:33:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1404281	Novus Therapeutics Inc.	NVUS	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1705278	C. Catherine Turkel	C/O Novus Therapeutics, Inc. 19900 Macarthur Blvd., Suite 550 Irvine CA 92612	Chief Development Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-05-10	11,111	$9.99	24,519	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

All numbers give effect to the 1:9 reverse stock split effected by the Company on May 11, 2017.